VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Clinical trials for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
New drug cocktail offers hope for rare tumor patients
Disease control OngoingThis study tests whether combining two immunotherapy drugs, atezolizumab and bevacizumab, can shrink or control rare solid tumors that are hard to treat. About 133 adults with cancers like rare appendix, anal, cervical, penile, vulvar, neuroendocrine, Merkel cell, nasopharyngeal,…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:23 UTC
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky or advanced cancer will be randomly assigned to receive either standa…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC